跳到正文
原文
Endpoints News· @endpts · X·· 4 小时前精选AI 评分58
AI 导读

Caribou 因未能获得融资,暂停两项同种异体 CAR-T 项目,并正在考虑出售或合并。相关报道链接为 https://endpoints.news/car-t-biotech-caribou-weighs-its-options-after-struggling-to-find-funding/。

推荐理由

Caribou 在融资受阻后暂停两项同种异体 CAR-T 项目并考虑出售或合并,可观察细胞治疗企业的资金压力。

正文

Caribou is shelving two allogeneic CAR-T programs and weighing a sale or merger after failing to secure funding. https://endpoints.news/car-t-biotech-caribou-weighs-its-options-after-struggling-to-find-funding/?utm_source=Twitter&utm_medium=organic_social&utm_campaign=editorial

来源:Endpoints News · x.com